Haematological Malignancies

	09/21/2009	Managing Treatment- and Disease-Related Complications in Multiple Myeloma
	09/21/2009	Thrombosis in Multiple Myeloma: Choice of Thromboprophylaxis Depends on Type of Therapy and Individual Risk of Patient
	09/21/2009	Peripheral Neuropathy in Multiple Myeloma: Early Recognition and Intervention Key to Minimize Long-Term Complications
	09/21/2009	Myeloma Bone Disease: Is Targeting of Osteoclastic and Osteoblastic Mechanisms Necessary for Effective Therapy?
	08/17/2009	Questioning Clinical Assumptions in Accelerated-Phase and Blast-Crisis CML
	08/17/2009	How Can We Clarify Treatment Approaches in High-Risk CML?
	08/17/2009	How Can We Improve Treatment & Outcome in Blast-Crisis CML?
	07/16/2009	Achieving Optimal Management of High-Risk CLL
	07/16/2009	Selecting Treatment for an Adult Male Patient With CLL and High-Risk Cytogenetic Features
	07/16/2009	Managing an Elderly Male Patient With CLL Failing Initial Therapy
	07/02/2009	State of the Science in Multiple Myeloma: Which New Therapies Have Convincingly Demonstrated Improvements in Efficacy?
	07/02/2009	Assessing the Benefits of Novel Therapies in Newly Diagnosed Multiple Myeloma: Clinical and Research Implications of the Latest Trials
	07/02/2009	Assessing the Benefits of Novel Therapies in Relapsed/Refractory Multiple Myeloma: Clinical and Research Implications of Latest Trials
	05/22/2009	Optimizing Bone Health Management in Multiple Myeloma
	05/22/2009	Understanding the Development of Myeloma Bone Disease and Novel Targets for Therapy
	05/22/2009	Interpreting New Data on Established and Emerging Therapies for Improving Bone Health in Multiple Myeloma
	05/14/2009	Applying Key Biomarkers in Oncology: From Biospecimen Preparation and Storage to Clinical Implications
	05/13/2009	Evaluating Innovative Strategies in Relapsed/Refractory Mantle-Cell Lymphoma
	04/22/2009	Evaluating New Data in Iron Overload: Updates on Chelation Therapy in Transfusional Disease
	03/03/2009	Exploring New Trends in MDS & AML: From Clinical Data in Poor-Prognosis Patients to Mechanisms of Novel Agents
	03/03/2009	Interpreting New Findings on Epigenetic Changes in MDS and AML-What Impact Will They Have on Treatment?
	03/03/2009	Do Modified Treatment and Novel Therapies Augment Clinical Benefit in AML?
	03/03/2009	Crafting an Individualized Approach to MDS Therapy: New Data on Prognostic Models and Management of Higher Risk Disease
	02/16/2009	Hematology Data Update From San Francisco: Emerging Clinical Trends Across Malignant Settings
	11/26/2008	Maximizing Outcomes in CML Throughout the Treatment Continuum
	11/26/2008	Long-Term Management of a Patient With Newly Diagnosed, Chronic-Phase CML
	11/26/2008	Choosing Appropriate Second-Line Therapy for a Patient With Progressive/Treatment-Resistant CML
	09/29/2008	Assessing Modern Multiple Myeloma Treatment: From Novel Induction Strategies to Modified Regimens in Relapsed/Refractory Disease
	09/12/2008	Exploring Epigenetic Targets in Solid Tumors and Hematologic Malignancies
	09/12/2008	Understanding Targets of Epigenetic Therapy in Cancer